BCL2 and melanoma: 2.3. LNPs Carrying Therapeutic miRNAs Effectively Overexpress miR-204-5p and miR-199b-5p in Melanoma Cells and in Turn Inhibit Their Target Oncogenes Bcl-2 and VEGF-A